The Index
400 dossiers
A research screener for every company we cover. Search a name or ticker, then sort and triage dossiers by coverage freshness, our conviction and trading relevance.
| A genuinely deleveraged, vertically-integrated aluminum pure-play whose 2025-26 earnings recovery is being borrowed from a tariff — ~60% of US aluminum volume rides a Section-232-inflated Midwest premium that is a policy decision away from evaporating; own the cycle, not the multiple. | — | 1 | |
| A copper compounder still priced as an iron-ore proxy — the re-rate is real but gated on iron ore not breaking before copper volumes arrive (2028+), and Jansen's serial cost blowouts are the tell that BHP's build muscle has atrophied. | — | 8 | |
| The best-in-class Western uranium franchise with a free option on a nuclear-construction renaissance — but the market already owns it at ~35x forward EV/EBITDA and ~50x earnings, pricing the Westinghouse $80B build-out and a structural uranium deficit as near-certainties when the asset is operationally fragile (chronic mine shortfalls) and Westinghouse still loses money at the net line. Great company, demanding price; WATCHING for a multiple reset or an operational/contracting catalyst. | — | 8 | |
| The only U.S.-owned enrichment platform with an NRC HALEU license and a $900M DOE expansion award — but it is still a sub-scale fuel broker living on a Russian supply contract that dies in 2028, priced at 50–60x earnings for a build-out that is contingent on money it does not yet have. | — | 1 | |
| The single most tariff- and operationally-levered way to own a structurally walled-off US aluminum price — a high-beta, low-EV/EBITDA call levered to a record Midwest premium, gated by a Glencore-controlled cap table, a Jamalco material weakness, and a hedge book bleeding against its own thesis. | — | 1 | |
| A leveraged, blast-furnace cyclical printing its worst losses since the acquisition spree — but the tariff-supported price floor is already bending the loss curve up, and the stock has nearly doubled off the low pricing much of that recovery in. Bullish on the operating turn, but the debt + dilution + cash-burn make this a high-beta option, not a compounder. | — | 1 | |
| A world-class copper-and-gold orebody wrapped in a structurally leaky holding company — you buy FCX for the copper supercycle and the Grasberg restart, but ~half of every Indonesian dollar exits to the Indonesian state before it reaches your share, and Grasberg execution (not the copper price) is what actually decides the stock through 2027. | — | 1 | |
| A levered, structurally-loss-making graphite-electrode pure-play whose old take-or-pay earnings are gone, now priced as a distressed call option on a 2026 electrode-price recovery that has to clear a 2029 debt wall — own the bonds' problem, not the equity, until pricing turns or the balance sheet is fixed. | — | 1 | |
| A single-asset US copper developer (Santa Cruz) levered to a structural copper deficit and the "domestic critical-minerals" trade, wrapped in a Friedland promote and a still-unfunded $1.24B build — own the deposit and the EXIM optionality, but underwrite the dilution, not the PFS NPV. | — | 1 | |
| The record 2026 print is mostly a Section-232 tariff-premium + metal-price-lag windfall on flat real volume — a high-quality fabricator priced for perfection at a 52-week high after a 2.5x run, with consensus already pointing down. | — | 1 | |
| An irreplaceable U.S. beryllium monopoly wrapped in a low-margin pass-through metals business and now priced like a secular-growth compounder (~34x fwd vs 18-20x historical, above every Street target) — the asset is real, the multiple is the bet. | — | 1 | |
| A subsidized option on Western rare-earth independence — the DoD's $110/kg NdPr floor turned a money-losing concentrate miner into a vertically-integrated magnet company with capped downside, but the equity already prices the 2028+ 10X build at ~134x forward earnings, so you're paying full freight for a thesis that depends on execution and elevated NdPr prices. | — | 1 | |
| The tariff-fortified, lowest-cost EAF compounder is mid-upcycle with self-help volume still to land — but the +118% run already prices the recovery, so the edge is the multi-year normalized-earnings step-up, not the next print. | — | 1 | |
| A de-risked, debt-light gold royalty toll-bridge that just doubled in size via Sandstorm yet trades at a ~7-9x P/E discount to Franco-Nevada and Wheaton — the discount is the thesis, not the warning. | — | 1 | |
| The world's lowest-cost, longest-reserve, highest-margin copper pure-play — a generational asset wrapped in a Sell-rated price and 88.9% Grupo Mexico control; you want the orebody, not the multiple, and the market agrees. | — | 1 | |
| Best-in-class low-cost EAF compounder riding a tariff-fattened spread into a stock that already prices the good news — the edge is the aluminum option and through-cycle discipline, not the current multiple. | — | 1 | |
| The world's #1 vertically-integrated TiO2 producer is a high-quality asset trapped under an 11.1x-levered balance sheet in the worst pigment down-cycle in a decade — the equity is a leveraged call option on a 2027 cyclical recovery (plus a free rare-earth lottery ticket), not an investment, and the 2029 maturity wall is the clock. | — | 1 | |
| A ~$1.1B market cap wrapped around a ~$40M-revenue, loss-making smelter — the only US vertically-integrated antimony producer, priced almost entirely on a back-end-loaded $125M federal-ramp promise from a serially-promotional CEO; own the antimony scarcity story, but the equity is a momentum/policy option, not a value asset. | — | 1 | |
| A leveraged, no-reserves bet on the U.S. uranium-independence trade dressed as an operating miner — production is real but trivial, the share count is the business model, and at ~300x sales you are paying for the spot price and the policy narrative, not the P&L. | — | 1 | |
| A pre-revenue mine-to-magnet roll-up that the U.S. government has chosen to underwrite — own the policy-protected build-out, not the ~240x-sales price; the bet is execution-by-2027, and the kill-switch is a single slipped milestone meeting a $5.5B valuation with $23M of revenue. | — | 0 |